The French pharmaceutical giant Ipsen is opening its new accelerator in Boston in April — and it’s already signed its first tenant.
The vaccine startup Affinivax will be moving from LabCentral to the new incubator, at 650 E. Kendall St. in Cambridge, which will open later this spring as long as all the required permits clear, according to new information shared at a Thursday meeting of the Cambridge Biosafety Committee.
About the Author Reprints
